Clin2
NCT07416747Possibly a fitNot yet recruiting

Probiotic supplement with therapy for mild to moderate depression

DepressionDepression DisorderDepression in Adults

Part of Mental health clinical trials.

This trial tests if a probiotic supplement (GynMDD) can boost the effects of supportive therapy for people with mild to moderate depression. If you're not taking antidepressants and have no suicidal thoughts, this may be an option for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
168 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You have mild to moderate depression (confirmed by a doctor's assessment)
  • You have no suicidal thoughts
  • Your body mass index (BMI) is between 19 and 29
  • You are not currently taking antidepressants or anxiety medications
  • You are willing to attend scheduled therapy sessions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05568498Recruiting· Phase 2
Probiotic trial for depression in Parkinson’s disease

This Phase 2 study tests whether taking probiotics can improve depression and mood symptoms in people with Parkinson’s disease. It’s meant for those with mild to moderate depression and stable Parkinson’s and mood treatments.

Vancouver, British Columbia
NCT06898788Recruiting· Early Phase 1
Probiotics for depression in teens and young adults

This study tests whether a probiotic supplement can help improve depression in young people who are already taking an SSRI antidepressant. If you join, you will take a probiotic or placebo for several weeks and have your mood and brain activity checked.

San Francisco, California
NCT06793397Recruiting· Phase 3
Study of an experimental psychedelic-like drug for depression (CYB003)

This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.

Birmingham, Alabama
NCT07182890Recruiting· Phase 4
Probiotic for anxiety and depression in functional dyspepsia

This trial tests whether a probiotic called Clostridium Butyricum can help reduce anxiety and depression in people with functional dyspepsia (a type of stomach discomfort without a clear cause). If you have mild to moderate anxiety or depression along with your stomach symptoms, this study may offer a potential new treatment option.

Xi’an, Shanxi
NCT07187492Recruiting· Phase 4
Can a probiotic ease anxiety and depression in functional dyspepsia?

This trial tests whether a probiotic called Bacillus coagulans can help reduce anxiety and depression in people with functional dyspepsia, a condition that causes stomach pain or discomfort without a clear physical cause. You may qualify if you have mild to moderate anxiety or depression alongside your stomach symptoms.

Xi’an, Shanxi
NCT07728253Not yet recruiting
Probiotic for moderate to severe depression

This trial tests a probiotic called IBNI617 for people with moderate to severe depression who are not currently taking antidepressant medication. It aims to see if this probiotic can help improve mood and depression symptoms.

Shanghai

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.